Abstract
Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.
Keywords: Allosteric modulation, allosteric antagonism, biased agonism, drug discovery, positive allosteric modulation efficacy, receptor theory
Current Topics in Medicinal Chemistry
Title:Allosteric Drugs and Seven Transmembrane Receptors
Volume: 13 Issue: 1
Author(s): Terry Kenakin
Affiliation:
Keywords: Allosteric modulation, allosteric antagonism, biased agonism, drug discovery, positive allosteric modulation efficacy, receptor theory
Abstract: Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.
Export Options
About this article
Cite this article as:
Kenakin Terry, Allosteric Drugs and Seven Transmembrane Receptors, Current Topics in Medicinal Chemistry 2013; 13 (1) . https://dx.doi.org/10.2174/1568026611313010003
DOI https://dx.doi.org/10.2174/1568026611313010003 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design Outcomes with Dronedarone in Atrial Fibrillation: What Differences Between Real-World Practice and Trials? A Meta-Analysis and Meta-Regression Analysis
Current Pharmaceutical Design Targeting Calmodulin in Reversing Multi Drug Resistance in Cancer Cells
Mini-Reviews in Medicinal Chemistry Antimetastatic Activities and Mechanisms of Bisdioxopiperazine Compounds
Anti-Cancer Agents in Medicinal Chemistry Anthracyclines Still Prove Effective in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
Current Pharmaceutical Design Subject Index to Volume 10
Current Medicinal Chemistry Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with Type 2 Diabetes?
Vascular Disease Prevention (Discontinued) Immune-Mediated Mechanisms in Atherosclerosis: Prevention and Treatment of Clinical Manifestations
Current Pharmaceutical Design HSP70 Family in the Renal Inflammatory Response
Inflammation & Allergy - Drug Targets (Discontinued) Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Modulation of Fatty Acids Oxidation in Heart Failure by Selective Pharmacological Inhibition of 3-Ketoacyl Coenzyme-A Thiolase
Current Clinical Pharmacology Metalloprotein Inhibitors for the Treatment of Human Diseases
Current Topics in Medicinal Chemistry Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction?
Current Diabetes Reviews NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome
Current Pharmaceutical Design Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents A Novel, Biodegradable, Thermoresponsive Hydrogel Attenuates Ventricular Remodeling and Improves Cardiac Function Following Myocardial Infarction - a review
Current Pharmaceutical Design